Jump to content

LOG IN




Forgotten password

WANT TO JOIN THE RQA?

Membership is open to all those with an interest in the quality and integrity of scientific research and development and those working with, or interested in, Good Laboratory, Clinical or Manufacturing Practice regulations or Pharmacovigilance, be they from industry, government, academia or contract research and wherever in the world they are based.

Non Member Email Bulletin LHP

Professional Development Courses & Seminars

QA Profession

Welcome to the RQA website

As an Association dedicated to informing and advancing its members, we provide status and visibility for individuals concerned with the quality of research in pharmaceuticals, agrochemicals, chemicals and medical devices. Since its beginnings in 1977, the Association has grown and developed to reflect regulatory changes, the impact of regulatory inspection and the changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research and development.

Click here to view our vision and mission statement.

2016 Membership Renewals

Membership renewals were due by 1st February 2016. If you haven't already, please log in to the Members Area to renew your membership.

Association Excellence Awards 2016

We are happy to announce that we have been selected as one of the finalists for the following categories in The Association Excellence Awards 2016.


2nd European QA Conference


The 2nd QA Conference will take place at the Nice Acropolis, Nice, France during the 27-29 April 2016.

Delegate, Exhibitor and Sponsorsghip bookings are now open.

Click here to visit the 2nd European QA Conference site to view the full programme and to book online

 

Latest News Items

Recruitment opportunities on website

There are new recruitment opportunities on the website

Read more >


ICH E18 Guideline reaches Step 2b of the ICH Process

The ICH E18 Guideline on Genomic Sampling and Management of Data reaches Step 2b of the ICH Process in December 2015 and now enters the consultation period (Step 3). This new guideline is proposed to provide guidance on genomic sample collection to evaluate efficacy and safety of a drug for regulatory approval.

Read more >


> More News

eLearning Access

On-Demand Webcasts